Reuters logo
BRIEF-AveXis to report top-line data from phase 1 clinical trial of AVXS-101
October 3, 2017 / 12:32 PM / in 17 days

BRIEF-AveXis to report top-line data from phase 1 clinical trial of AVXS-101

Oct 3 (Reuters) - AveXis Inc

* AveXis to report top-line data from the Phase 1 clinical trial of AVXS-101 in SMA Type 1 at the International Annual Congress Of The World Muscle Society

* AveXis Inc - there were no new treatment-related adverse events identified

* AveXis Inc - ‍all patients were alive and event-free at 20 months of age as of August 7, 2017 data cut-off​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below